Diabetes mellitus (DM): Nursing process (ADPIE)

3,865views

Diabetes mellitus (DM): Nursing process (ADPIE)

Watch later

Watch later

Antibiotics - Glycopeptides: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Blood products: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Analgesics: Nursing pharmacology
Antihistamines: Nursing pharmacology
Therapeutic communication: Nursing
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Immunoglobulins: Nursing pharmacology
Physiologic changes - Postpartum: Nursing
Assessment - Postpartum: Nursing
Cesarean birth: Nursing
Postpartum infections: Nursing
Assessment of gestational age: Nursing
Nutrition - Newborn: Nursing
Newborn adaptation to extrauterine life: Nursing
Hemolytic disease of the fetus and newborn: Nursing
Physical assessment - Neonate: Nursing
Group B streptococcus (GBS) infection in pregnancy: Nursing
Neonatal eye prophylaxis: Nursing pharmacology
Streptococcus agalactiae (Group B Strep)
Hyperbilirubinemia: Nursing process (ADPIE)
Large for gestational age (LGA) infant: Nursing
Hepatitis B virus (HBV) infection in pregnancy: Nursing
Brachial plexus injury: Nursing
Postpartum hemorrhage: Nursing
Psychosocial changes - Postpartum: Nursing
Oxytocin: Nursing pharmacology
Rho(D) immune globulin: Nursing pharmacology
Perinatal depression: Nursing
Shoulder dystocia: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Shock - Hypovolemic: Nursing
Eye conditions: Inflammation, infections and trauma: Pathology review
Otitis media: Nursing
Ventricular septal defect
Disseminated intravascular coagulation (DIC): Nursing
Antepartum assessment - Fetus: Nursing
Common discomforts of pregnancy: Nursing
Ectopic pregnancy: Nursing
Fetal circulation: Nursing
Fetal development: Nursing
Gestational trophoblastic disease: Nursing
Hyperemesis gravidarum: Nursing
Multiple gestation: Nursing
Physiologic changes - Pregnancy: Nursing
Pregestational conditions: Nursing
Psychosocial changes - Pregnancy: Nursing
Spontaneous abortion: Nursing
Placenta previa: Nursing process (ADPIE)
Placental abruption: Nursing process (ADPIE)
Ergot alkaloids: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Analgesics for obstetrics: Nursing pharmacology
Tocolytics: Nursing pharmacology
Prenatal care: Nursing
Preeclampsia and eclampsia: Nursing
Neonatal abstinence syndrome: Nursing
Sudden infant death syndrome (SIDS): Nursing
ADHD: Information for patients and families (The Primary School)
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Cerebral palsy: Nursing
Failure to thrive (FTT): Nursing
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Contraception - Barrier methods: Nursing
Syphilis: Nursing
Chlamydia trachomatis
Candidiasis: Nursing process (ADPIE)
Treponema pallidum (Syphilis)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Genital warts: Nursing
Contraception - Hormonal methods: Nursing
Dementia: Nursing
Alzheimer disease
Antiepileptics: Nursing pharmacology
Dyslipidemias: Pathology review
Schizophrenia: Nursing
Bipolar and related disorders
Mood stabilizers: Nursing pharmacology
Erectile dysfunction
Obsessive-compulsive disorder (OCD): Nursing
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Renal and urinary calculi: Nursing
Antipsychotics: Nursing pharmacology
Physical assessment - Mental status: Nursing
Delirium: Nursing
Restraints
Cataracts: Nursing
Glaucoma: Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Physical assessment - Peripheral vascular system: Nursing
Peripheral venous disease (PVD): Nursing process (ADPIE)
Amputation: Nursing
Treatment for Helicobacter pylori: Nursing pharmacology
Macular degeneration: Nursing
Eye conditions: Retinal disorders: Pathology review
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Thrombosis syndromes (hypercoagulability): Pathology review
Pulmonary embolism
Heart failure
Heart failure: Pathology review
Left-sided heart failure: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Nephrotic syndrome: Nursing
Immune response - Adaptive: Nursing
Inflammatory process: Nursing
Inflammation
Tuberculosis (TB): Nursing
Leukemia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Lung cancer: Nursing
Biology of cancer: Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
HIV (AIDS)
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type IV: Nursing
Physical assessment - Neurological system: Nursing
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Stroke: Nursing process (ADPIE)
Shock - Septic: Nursing
Shock - Neurogenic: Nursing
Burn injury: Nursing
Thermoregulation : Nursing
Arrhythmias - Atrial flutter (Aflutter): Nursing
Arrhythmias - Atrial fibrillation (Afib): Nursing
Arrhythmias - Supraventricular tachycardia (SVT): Nursing
Arrhythmias - Ventricular tachycardia (Vtach): Nursing
Arrhythmias - Ventricular fibrillation (Vfib): Nursing
Arrhythmias - Premature atrial contractions (PACs): Nursing
Arrhythmias - Premature ventricular contractions (PVCs): Nursing
Arrhythmias - Asystole: Nursing
Arrhythmias - Sinus tachycardia and sinus bradycardia: Nursing
ECG rate and rhythm
Cardiomyopathy: Nursing
Shock - Cardiogenic: Nursing
Endocarditis: Nursing
Cardiac preload
Acute respiratory distress syndrome (ARDS): Nursing
Neonatal respiratory distress syndrome (NRDS): Nursing
Chronic kidney disease (CKD): Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Dialysis care: Nursing
Aortic aneurysm: Nursing process (ADPIE)

Notes

DIABETES MELLITUS

KEY POINTS
NOTES
PATIENT REPORT
  • 63-year-old man
  • History type 2 diabetes
  • Metformin, glyburide
  • Hemoglobin A1C 8.9%
  • Numbness in feet

PATHOPHYSIOLOGY
  • Diabetes
    • Glucose unable to move from blood into cells
    • Cells starve for energy despite high glucose levels
    • Insulin's function impaired
    • Type 1
      • Autoimmune destruction of pancreatic beta cells
    • Type 2
      • Cells resistant to insulin
  • Insulin
    • Produced by pancreatic beta cells
    • Stimulates uptake of glucose into cells
  • Signs and symptoms
    • Polyuria
    • Polydipsia
    • Polyphagia
    • Diabetic ketoacidosis
    • Hyperosmolar hyperglycemic state
  • Complications
    • Peripheral vascular disease
    • Myocardial infarction
    • Stroke
    • Nephropathy
    • Retinopathy
    • Neuropathy
    • Ulcers

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • Measuring blood glucose levels
    • Hemoglobin A1C
  • Treatment
    • Insulin
    • Lifestyle changes
    • Oral or injectable antidiabetic medications

ASSESSMENT
  • Glucose running high last few months
    • > 200 mg/dL (11.1 mmol/L) most of the time
  • Takes medications as prescribes
  • Avoids sweets 
  • Does not follow particular diet
  • Occasional yard work and gardening
  • Recent numbness in feet
  • Cool and dry feet
  • 2+ pedal pulses
  • Temperature: 97.9 F (36.6 C)
  • Heart rate: 68
  • Respiratory rate: 18
  • Lungs clear
  • Blood pressure: 142/80 mmHg
  • Pain: 0/10
  • Oxygen saturation: 96% room air
  • 5'11''
  • 192 lbs (87 kg)
  • Hemoglobin A1C: 8.9%
  • Fasting glucose: 117 mg/dL (6.5 mmol/L)
  • Monofilament test: moderate loss of sensation in feet bilaterally

NURSING DIAGNOSES
  • Unstable blood glucose related to insufficient diabetes management
  • Risk for injury related to impaired peripheral arterial circulation and decreased neurosensory function
  • Readiness for enhanced health management related to desire to prevent complications

PLANNING
  • Maintain glucose in normal range
  • Reduce A1C
  • Keep feet free from injury and sores
  • Incorporate treatments into lifestyle 

IMPLEMENTATION
  • Teach about long-acting insulin
  • Regular glucose monitoring
  • Keep regular appointments
  • How to recognize hypoglycemia
  • Adverse effects to report
  • Lifestyle changes
  • Foot care
  • Develop personalized meal plan

EVALUATION
  • Hemoglobin A1C: 7.9%
  • Glucose log averages 170-190 mg/dL (9.4-10.6 mmol/L)
  • Increased physical activity
  • Making healthier food choices
  • Weight loss of 8 lbs
  • No sores or cracking on feet

Transcript

Watch video only

Harold Owl is a 63-year-old male client with a history of type 2 diabetes who is referred to the endocrinology clinic by his primary care provider for evaluation.

Mr. Owl takes the biguanide metformin and sulfonylurea glyburide to manage his diabetes, but his latest hemoglobin A1c, or HbA1c test, was 8.9% and he has recently developed numbness in his feet.

In diabetes mellitus, commonly just called diabetes, the body has trouble moving glucose from the blood into the tissue cells.

As a result, cells starve for energy despite having high blood glucose levels, which is called hyperglycemia.

Normally, high blood glucose stimulates the pancreatic beta cells to produce and secrete the hormone insulin, which in turn reduces blood glucose by stimulating the uptake of glucose into the cells. In diabetes, the blood glucose stays high because insulin’s function is impaired.

There are two main types of diabetes. In type 1 diabetes, there’s autoimmune destruction of the pancreatic beta cells, so they can’t produce and secrete insulin.

The exact cause of type 1 diabetes is unknown, but it’s thought to have a genetic and environmental component, and risk factors include personal or family history of type 1 diabetes, as well as celiac disease, and thyroid disease.

The onset is usually abrupt, generally appears before the age of 30, and is most often diagnosed during childhood or puberty.

On the other hand, in type 2 diabetes, the pancreas is able to produce and secrete insulin, but the tissue cells tend to be insulin resistant, meaning they are unable to respond well to insulin stimulation.

Type 2 diabetes is associated with risk factors, like male sex, increasing age, or having a first degree relative with type 2 diabetes, a body mass index or BMI over 25, a sedentary lifestyle, or a cardiovascular disease like hypertension.

With type 2 diabetes, the symptoms usually begin after the age of 45, and gradually worsen over a few months.

Classic symptoms of both type 1 and type 2 diabetes include polyuria, which means that individuals urinate frequently, which is associated with polydipsia, which means they are constantly thirsty and drink a lot of water.

Many clients also present with polyphagia, which is a fancy way to say they have a large appetite, and is associated with unexplained weight loss because tissue cells can’t uptake the glucose from food, so they instead use fatty acids from adipose tissue, called lipolysis.

Now, clients with type 1 diabetes are at risk for a serious acute complication called diabetic ketoacidosis, or DKA for short.

This occurs because, after lipolysis, the liver turns the fatty acids into ketone bodies, which increase the acidity of the blood.

As a result, clients can develop nausea, vomiting, dehydration, and a characteristic fruity smelling breath, as well as a deep and labored breathing called Kussmaul respirations.

Severe cases of DKA can also cause mental status changes and acute cerebral edema.

An acute complication that is much more common in type 2 diabetes is called hyperosmolar hyperglycemic state, or HHS, which is characterized by extreme hyperglycemia, along with increased urination.

This can cause severe dehydration, as well as nausea, vomiting, and mental status changes.

Alright, now over time, the hyperglycemia that occurs with uncontrolled diabetes can cause damage to the blood vessels, leading to long-term or chronic complications.

These include macrovascular complications due to damage to the larger blood vessels, resulting in peripheral vascular disease, myocardial infarction, and stroke.

Diabetes can also cause microvascular complications due to damage to the tiny blood vessels throughout the body.

In the kidneys, microvascular damage ultimately leads to diabetic nephropathy, which causes renal insufficiency and failure. In the eyes, microvascular damage can lead to diabetic retinopathy and can eventually cause blindness.

Diabetes can also affect the peripheral nerves, causing diabetic neuropathy, which is characterized by decreased sensation in the toes and fingers, sometimes called a stocking-glove distribution, as well as autonomic neuropathy, resulting in problems like delayed gastric emptying, called gastroparesis, as well as urinary retention, or neurogenic bladder, and erectile dysfunction in males.

Finally, a combination of microvascular damage and neuropathy can lead to the formation of diabetic foot ulcers, which can become infected easily, are slow to heal, and increase the risk of lower extremity amputation.

Diagnosing type 1 or type 2 diabetes is typically done by measuring blood glucose levels.

A random blood sample can be taken anytime, or very commonly, a fasting glucose sample where the person doesn’t eat or drink anything except water for 8 hours.

A fasting blood glucose level of 100-125 mg/dL is considered prediabetes, and if it's 126 mg/dL or higher on two separate occasions, the client has diabetes.

A non-fasting or random glucose test can be done at any time, with 200 mg/dL or higher being a red flag for diabetes.

Another test is called an oral glucose tolerance test, where a person is given glucose, and then blood samples are taken at time intervals to figure out how well it’s being cleared from the blood.

At the time interval of 2 hours later, a glucose level of 200 or above indicates diabetes.

Another type of test that can be done is the HbA1c test, which tests for the proportion of hemoglobin in red blood cells that has glucose stuck to it, called glycosylated hemoglobin.

Sources

  1. "Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care, 13th edition" Mosby (2022)
  2. "Genetics of diabetes mellitus and diabetes complications" Nat Rev Nephrol (2020)
  3. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  4. "Definition, Classification and Diagnosis of Diabetes Mellitus" Exp Clin Endocrinol Diabetes (2019)
  5. "Diabetes, cardiovascular disease and the microcirculation" Cardiovasc Diabetol (2021)
  6. "Critical Care Nursing: Diagnosis and Management, 9th edition" Elsevier (2021)